Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)

Trial Profile

Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Feb 2017

At a glance

  • Drugs Dornase alfa (Primary) ; Alteplase
  • Indications Embolism and thrombosis; Empyema
  • Focus Therapeutic Use
  • Acronyms DTPA
  • Most Recent Events

    • 13 Feb 2017 Planned End Date changed from 1 Apr 2015 to 1 Dec 2017.
    • 13 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 23 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top